Many studies have reported that perturbation of TGF‐β signaling is often considered a pathogenic factor in tumor progression due to its tumor‐promoting effects or tumor suppressor effects (Butz et al., 2012; Ikushima and Miyazono, 2010). The gene discussed is TGFB1; the disease is neoplasm.